Literature DB >> 19393702

Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery.

Deborah M Sweet1, Rohit B Kolhatkar, Abhijit Ray, Peter Swaan, Hamidreza Ghandehari.   

Abstract

The purpose of this work was to assess the impact of PEGylation on transepithelial transport of anionic poly(amidoamine) dendrimers. Cytotoxicity, uptake and transport across Caco-2 cells of PEGylated G3.5 and G4.5 PAMAM dendrimers were studied. Methoxy polyethylene glycol (750 Da) was conjugated to carboxylic acid-terminated PAMAM dendrimers at feed ratios of 1, 2 and 4 PEG per dendrimer. Compared to the control, PEGylation of anionic dendrimers did not significantly alter cytotoxicity up to a concentration of 0.1 mM. PEGylation of G3.5 dendrimers significantly decreased cellular uptake and transepithelial transport while PEGylation of G4.5 dendrimers led to a significant increase in uptake, but also a significant decrease in transport. Dendrimer PEGylation reduced the opening of tight junctions as evidenced by confocal microscopy techniques. Modulation of the tight junctional complex correlated well with changes in PEGylated dendrimer transport and suggests that anionic dendrimers are transported primarily through the paracellular route. PEGylated dendrimers show promise in oral delivery applications where increased functionality for drug conjugation and release is desired.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393702      PMCID: PMC2818763          DOI: 10.1016/j.jconrel.2009.04.022

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  35 in total

Review 1.  Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.

Authors:  Suphiya Parveen; Sanjeeb K Sahoo
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration.

Authors:  Tatsuya Okuda; Shigeru Kawakami; Tadahiro Maeie; Takuro Niidome; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  J Control Release       Date:  2006-05-23       Impact factor: 9.776

3.  Evaluation of Biocoat intestinal epithelium differentiation environment (3-day cultured Caco-2 cells) as an absorption screening model with improved productivity.

Authors:  S Chong; S A Dando; R A Morrison
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

4.  Enhanced transepithelial transport of peptides by conjugation to cholic acid.

Authors:  P W Swaan; K M Hillgren; F C Szoka; S Oie
Journal:  Bioconjug Chem       Date:  1997 Jul-Aug       Impact factor: 4.774

5.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications.

Authors:  R Esfand; D A. Tomalia
Journal:  Drug Discov Today       Date:  2001-04-01       Impact factor: 7.851

6.  In vitro evaluation of dendrimer prodrugs for oral drug delivery.

Authors:  Mohammad Najlah; Sally Freeman; David Attwood; Antony D'Emanuele
Journal:  Int J Pharm       Date:  2006-11-28       Impact factor: 5.875

7.  Size-dependent permeability of hydrophilic probes across rabbit colonic epithelium.

Authors:  H Ghandehari; P L Smith; H Ellens; P Y Yeh; J Kopecek
Journal:  J Pharmacol Exp Ther       Date:  1997-02       Impact factor: 4.030

8.  Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.

Authors:  D A Tomalia; L A Reyna; S Svenson
Journal:  Biochem Soc Trans       Date:  2007-02       Impact factor: 5.407

9.  Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers.

Authors:  Amy B Foraker; Rob J Walczak; Michael H Cohen; Tony A Boiarski; Carl F Grove; Peter W Swaan
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

10.  PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.

Authors:  István J Majoros; Andrzej Myc; Thommey Thomas; Chandan B Mehta; James R Baker
Journal:  Biomacromolecules       Date:  2006-02       Impact factor: 6.988

View more
  26 in total

1.  Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia.

Authors:  Deborah S Goldberg; Hamidreza Ghandehari; Peter W Swaan
Journal:  Pharm Res       Date:  2010-04-22       Impact factor: 4.200

Review 2.  Poly(amido amine) dendrimers in oral delivery.

Authors:  Venkata K Yellepeddi; Hamidreza Ghandehari
Journal:  Tissue Barriers       Date:  2016-04-06

Review 3.  Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.

Authors:  S Sadekar; H Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2011-09-29       Impact factor: 15.470

4.  Oral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomes.

Authors:  Qian Ma; Yingchun Han; Cong Chen; Yini Cao; Siling Wang; Wenwen Shen; Huayu Zhang; Yanzhi Li; Mallory A van Dongen; Bing He; Maomao Yu; Lu Xu; Mark M Banaszak Holl; George Liu; Qiang Zhang; Rong Qi
Journal:  Mol Pharm       Date:  2015-01-27       Impact factor: 4.939

5.  Dendrimers for Ocular Drug Delivery.

Authors:  Michael G Lancina; Hu Yang
Journal:  Can J Chem       Date:  2017-05-11       Impact factor: 1.118

6.  Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice.

Authors:  S Sadekar; A Ray; M Janàt-Amsbury; C M Peterson; H Ghandehari
Journal:  Biomacromolecules       Date:  2010-12-03       Impact factor: 6.988

7.  Time-Resolved Proteomic Visualization of Dendrimer Cellular Entry and Trafficking.

Authors:  Linna Wang; Li Yang; Li Pan; Naveen Reddy Kadasala; Liang Xue; Robert J Schuster; Laurie L Parker; Alexander Wei; W Andy Tao
Journal:  J Am Chem Soc       Date:  2015-10-05       Impact factor: 15.419

Review 8.  Managing diabetes with nanomedicine: challenges and opportunities.

Authors:  Omid Veiseh; Benjamin C Tang; Kathryn A Whitehead; Daniel G Anderson; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-11-28       Impact factor: 84.694

9.  G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.

Authors:  Deborah S Goldberg; Nirmalkumar Vijayalakshmi; Peter W Swaan; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2010-11-27       Impact factor: 9.776

10.  The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents.

Authors:  Gaurav Sahay; Jong Oh Kim; Alexander V Kabanov; Tatiana K Bronich
Journal:  Biomaterials       Date:  2009-10-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.